| Literature DB >> 35268775 |
Yongjing Yang1,2, Xingxing Yin1, Dejun Zhang1,2, Jie Lu1, Xuehong Wang1.
Abstract
The discovery of safe and effective plant polysaccharides with immunomodulatory effects has become a research hotspot. Raspberry is an essential commercial fruit and is widely distributed, cultivated, and consumed worldwide. In the present study, a homogeneous acidic polysaccharide (RPP-2a), with a weight-average molecular weight (Mw) of 55582 Da, was isolated from the pulp of raspberries through DEAE-Sepharose Fast Flow and Sephadex G-200 chromatography. RPP-2a consisted of rhamnose, arabinose, galactose, glucose, xylose, galacturonic acid and glucuronic acid, with a molar ratio of 15.4:9.6:7.6:3.2:9.1:54.3:0.8. The results of Fourier transform infrared spectroscopy (FT-IR), gas chromatography-mass spectrometer (GC-MS), 1D-, and 2D-nuclear magnetic resonance (NMR) analyses suggested that the backbone of RPP-2a was primarily composed of →2)-α-L-Rhap-(1→, →2,4)-α-L-Rhap-(1→, →4)-α-D-GalAp-(1→, and →3,4)-α-D-Glcp-(1→ sugar moieties, with side chains of α-L-Araf-(1→, α-L-Arap-(1→, and β-D-Galp-(1→3)-β-D-Galp-(1→ residues linked to the O-4 band of rhamnose and O-3 band of glucose residues. Furthermore, RPP-2a exhibited significant macrophage activation activity by increasing the production of nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), and the expression of inducible nitric oxide synthase (iNOS) and cytokines at the transcriptional level in RAW264.7 cells. Overall, the results indicate that RPP-2a can be utilized as a potential natural immune-enhancing agent.Entities:
Keywords: acidic polysaccharide; macrophage activation; raspberry pulp; structural characterization
Mesh:
Substances:
Year: 2022 PMID: 35268775 PMCID: PMC8911918 DOI: 10.3390/molecules27051674
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(a) Elution profiles of RPPs by DEAE-Sepharose Fast Flow chromatography and (b) RPP-2 on a Sephadex G-200 column.
Figure 2Monosaccharide composition of RPP-2a. (a) The profile of mixed monosaccharides standards and (b) monosaccharides in RPP-2a.
Figure 3FT-IR spectra of RPP-2a ranging from 400 to 4000 cm−1.
Figure 4The homogeneity and molecular weight of RPP-2a.
Figure 5The GC-MS chromatogram of PMAAs of RPP-2a.
GC-MS analysis of methylated RPP-2a.
| Retention Time (min) | Methylated Sugar | Mass Fragments ( | Linkages Patterns | Molar Ratios |
|---|---|---|---|---|
| 9.455 | 2,3,5-Me3-Ara | 43,71,87,101,117,129,145,161 | Ara | 7.61 |
| 10.815 | 2,3,4-Me3-Ara | 43,71,87,101,117,129,131,161 | Ara | 5.69 |
| 14.377 | 3,4-Me2-Rha | 43,59,87,89,99,115,129,131,189 | →2)-Rha | 7.11 |
| 16.282 | 2,3,4,6-Me4-Glc | 43,71,87,101,117,129,145,161,205 | Glc | 1.70 |
| 17.459 | 2,3,4,6-Me4-Gal | 43,71,87,101,117,129,145,161,205 | Gal | 6.22 |
| 18.825 | 3-Me1-Rha | 43,87,101,117,129,143,159,189 | →2,4)-Rha | 5.53 |
| 20.511 | 3,4,6-Me3-Gal | 43,87,129,161,189 | →2-Gal | 0.89 |
| 21.222 | 2,3,6-Me3-Gal | 43,87,99,101,113,117,129,131,161,173,233 | →4)-Gal | 44.35 |
| 21.409 | 2,3,6-Me3-Glc | 43,87,99,101,113,117,129,131,161,173,233 | →4)-Glc | 0.66 |
| 22.182 | 2,4,6-Me3-Gal | 43,87,99,101,117,129,161,173,233 | →3)-Gal | 4.33 |
| 24.374 | 2,3,4-Me3-Gal | 43,87,99,101,117,129,161,189,233 | →6)-Gal | 0.79 |
| 24.888 | 2,6-Me2-Glc | 43,87,97,117,159,185 | →3,4)-Glc | 9.81 |
| 26.024 | 3,6-Me2-Glc | 43,87,99,113,129,173,189,233 | →2,4)-Glc | 2.15 |
| 27.815 | 2,3-Me2-Gal | 43,71,85,87,99,101,117,127,159,161,201 | →4,6)-Gal | 2.00 |
| 29.536 | 2,4-Me2-Gal | 43,87,117,129,159,189,233 | →3,6)-Gal | 1.16 |
Assignment of 1H and 13C NMR chemical shift values of RPP-2a.
| Sugar | Linkage Type | H1 | H2 | H3 | H4 | H5a/H5 | H5b/6a | H6b | OCH3 | OCH2CH3 |
|---|---|---|---|---|---|---|---|---|---|---|
| C1 | C2 | C3 | C4 | C5 | C6 | |||||
| A | →2)- | 5.22 | 3.18 | 3.69 | 3.4 | 3.67 | 1.14 | |||
| 101.1 | 77.86 | 70.9 | 73.1 | 73.2 | 17.8 | |||||
| B | →2)- | 5.21 | 3.80 | 3.96 | ns | 3.77 | 1.14 | |||
| 93.78 | 77.86 | 70.9 | ns | 71.5 | 17.8 | |||||
| C | →2,4)- | 5.17 | 4.02 | 3.56 | 3.86 | 3.77 | 1.14 | |||
| 99.5 | 77.86 | 73.9 | 78.18 | 71.5 | 17.8 | |||||
| D | 5.08 | 4.13 | 3.87 | 4.06 | 3.76 | 3.64 | ||||
| 108.45 | 82.62 | 77.79 | 85.22 | 62.64 | ||||||
| E | →3,4)- | 5.04 | 3.53 | 4.01 | 4.27 | 3.86 | 3.92 | 3.71 | ||
| 98.7 | 70.34 | 83.3 | 81.71 | 73.49 | 62.26 | |||||
| F | →4)- | 4.99 | 3.68 | 3.92 | 4.33 | 4.68 | ||||
| 100.39 | 69.8 | 70.12 | 79.68 | 72.92 | 176.66 | |||||
| G | 4.98 | 4.07 | 3.96 | 4.16 | 3.76 | 3.64 | ||||
| 109.23 | 82.52 | 78.12 | 83.6 | 62.64 | ||||||
| H | →4)- | 4.85 | 3.64 | 4.2 | 5.71 | 3.71 | ||||
| 101.88 | 72.7 | 67.2 | 109.16 | 146.8 | 172.15 | |||||
| I | →4)- | 4.84 | 3.66 | 3.91 | 4.36 | 5.05 | 3.74 | 1.96 | ||
| 100.81 | 69.54 | 69.79 | 80.06 | 72.96 | 172.19 | 54.4 | 22.2 | |||
| J | 4.56 | 3.63 | 3.72 | 3.62 | 3.67 | 3.74 | 3.66 | |||
| 105.74 | 73.12 | 74.64 | 69.6 | 75.9 | 62.11 | |||||
| K | →3)- | 4.52 | 3.47 | 3.6 | 3.97 | 3.64 | 3.69 | 3.86 | ||
| 104.69 | 71.97 | 78.1 | 70.25 | 76.4 | 62.26 | |||||
| L | →2)- | 4.5 | 4.01 | 3.96 | ns | 3.77 | 1.14 | |||
| 97.63 | 77.86 | 70.9 | ns | 71.5 | 17.8 |
The “ns” indicates “no significant difference”.
Figure 6NMR spectra and the suggested structure of RPP-2a. (a) 1H NMR. (b) 13C NMR. (c) DEPT-135. (d) HMBC. (e) NOESY. (f) HSQC. (g) COSY. (h) The structure of RPP-2a.
Figure 7Effect of RPP-2a on the viability of RAW264.7 cells. Data are presented as mean ± SD; * = p < 0.05 and ** = p < 0.01 vs. control group.
Figure 8Enhanced effects of RPP-2a on NO and proinflammatory cytokines production. (a) NO. (b) TNF-α. (c) IL-6. (d) IL-1β. Data are presented as mean ± SD; ** = p < 0.01 vs. control group.
Figure 9Effects of RPP-2a on the mRNA expression of iNOS and cytokines in RAW264.7 macrophages. The mRNA levels of (a) iNOS, (b) TNF-α, (c) IL-6, and (d) IL-1β were measured by qRT-PCR in the RPP-2a treated RAW264.7 cells. Data are presented as mean ± SD, n = 3, * = p < 0.05, and ** = p < 0.01 vs. control group.
PCR primers used in the measurement of mRNA expression.
| Target Gene | Primer |
|---|---|
| GADPH | forward primer: 5′-GGCCTTCCGTGTTCCTACC-3′ |
| reverse primer: 5′-TGCCTGCTTCACCACCTTC-3′ | |
| TNF-α | forward primer: 5′-GCCAGGAGGGAGAACAGAAACT-3′ |
| reverse primer: 5′-GGCCAGTGAGTGAAAGGGACA-3′ | |
| IL-6 | forward primer: 5′-GAGGATACCACTCCCAACAGACC-3′ |
| reverse primer: 5′-AAGTGCATCATCGTTGTTCATACA-3′ | |
| IL-1β | forward primer: 5′-GCCACCTTTTGACAGTGATGAG-3′ |
| reverse primer: 5′-GACAGCCCAGGTCAAAGGTT-3′ | |
| iNOS | forward primer: 5′-CCTGTGAGACCTTTGATG-3′ |
| reverse primer: 5′-CCTATATTGCTGTGGCTC-3′ |